[Frailty phenotype in older people living with HIV: concepts, prevention and issues]. / Le phénotype de fragilité chez les personnes vieillissantes avec le VIH : concepts, prévention et enjeux de prise en charge.
Geriatr Psychol Neuropsychiatr Vieil
; 17(2): 123-128, 2019 06 01.
Article
em Fr
| MEDLINE
| ID: mdl-31010801
ABSTRACT
The life-span of people aging with HIV (PHIV) tends to reach people without infection, reflecting the effectiveness and tolerance of antiretroviral treatment and improvement of multidisciplinary management. Comorbidities or HIV-inflammaging seems to be the main determinants of frailty phenotype in PHIV. Prevalence of frailty in PHIV is frequent (5% from 28%) and appears earlier than in general population (50 versus 65 years). Almost half of people with HIV present prefrail phenotype before 50 years. The usefulness of integrate routinely measures of frailty phenotype is not yet known but several data are encouraging in terms of feasibility and prediction. Early determination of frailty in PHIV could lead to target interventions to improve global health and decrease adverse outcomes such as incapacities and early death.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Infecções por HIV
/
Fragilidade
Tipo de estudo:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Aged
/
Aged80
/
Humans
Idioma:
Fr
Ano de publicação:
2019
Tipo de documento:
Article